Breadcrumb

null Nicole Basta, PhD, MPhil

Investigator, RI-MUHC, 5252 de Maisonneuve site

Infectious Diseases and Immunity in Global Health Program

Centre for Outcomes Research and Evaluation

Professor, Department of Medicine, Faculty of Medicine and Health Sciences and School of Population and Global Health, McGill University

 

Keywords

infectious disease epidemiology • vaccine-preventable diseases • vaccine epidemiology • global health • optimizing disease prevention and control strategies

Research Focus

My research improves disease prevention and control strategies for a broad range of diseases, including influenza, COVID-19, meningococcal and pneumococcal disease, RSV, shingles, HPV and measles. Drawing on infectious disease epidemiology, clinical epidemiology, vaccinology and public health, I design and analyze rigorous research to understand how long and how broadly vaccines protect, quantify their impact on population and patient health, and elucidate patterns of vaccine awareness, uptake and access, so that everyone can benefit from life-saving vaccines. I am the Canada Research Chair in Infectious Disease Prevention (Tier 2) and Associate Director of Clinical Research at the J.D. MacLean Centre for Tropical and Geographic Medicine.

Selected Publications

Click on Pubmed to see my current publications list

  • Scott J, Abers MS, Marwah HK, McCann NC, Meyerowitz EA, Richterman A, Fleming DF, Holmes EJ, Moat LE, Redepenning SG, Smith EA, Stoddart CJ, Sundaram ME, Ulrich AK, Alba C, Anderson CJ, Arpey MK, Borre E, Ladines-Lim J, Mehr AJ, Rich K, Watts C, Basta NE*, Jarolimova J*, Walensky RP*, Dugdale CM*. Updated Evidence for Covid-19, RSV, and Influenza Vaccines for 2025-2026. N Engl J Med. 2025 Dec 4;393(22):2221-2242. doi: 10.1056/NEJMsa2514268. Epub 2025 Oct 29. PMID: 41160817.

  • Bonner KE*, Chyderiotis S*, Sicsic J, Mueller J, Ulrich AK, Toomey T, Horvath KJ, Neaton JD, Basta NE. What motivates adults to accept influenza vaccine? An assessment of incentives, ease of access, messaging, and sources of information using a discrete choice experiment. SSM Population Health. 2023 Mar 14;22:101384. doi: 10.1016/j.ssmph.2023.101384. PMID: 37008807.

  • Basta NE, Sohel N, Sulis G, Wolfson C, Maimon G, Griffith LE, Kirkland S, McMillian JM, Thompson M, Raina P; Canadian Longitudinal Study on Aging (CLSA). Factors associated with willingness to receive a COVID-19 vaccine among 23,819 adults aged 50 years and older: An analysis of the Canadian Longitudinal Study on Aging. American Journal of Epidemiology. 2022 May 20;191(6):987-998. doi: 10.1093/aje/kwac029. PMID: 35166332.

  • Basta NE, Mahmoud AA, Wolfson J, Ploss A, Heller BL, Hanna S, Johnsen P, Izzo R, Grenfell BT, Findlow J, Bai X, Borrow R. Immunogenicity of a Meningococcal B Vaccine during a University Outbreak. N Engl J Med. 2016 Jul 21;375(3):220-8. doi: 10.1056/NEJMoa1514866. PMID: 27468058.